What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?
American Journal of Hematology · 2026-12 · 101 (12) · 3074-3076
DOI: 10.1002/ajh.70509 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 25.09.2026. Verfasst von Ruixuan Ai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shunde Women and Children's Hospital, Guangdong Medical University, Foshan, Guangdong, China. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shunde Women and Children's Hospital, Guangdong Medical University, Foshan, Guangdong, China.
- Xi'an Medical University, Xi'an, China.
ORCID-Profile: Yajun Wang
Zitieren
APA
Ai, R., Yang, Z., Hong, G., & Wang, Y. (2026). What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?. American Journal of Hematology, 101(12), 3074-3076. https://doi.org/10.1002/ajh.70509
Vancouver
Ai R, Yang Z, Hong G, Wang Y. What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?. American Journal of Hematology. 2026;101(12):3074-3076. doi:10.1002/ajh.70509
BibTeX
@article{Ai2026,
author = {Ai, Ruixuan and Yang, Zhenyu and Hong, Guanbang and Wang, Yajun},
title = {What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?},
journal = {American Journal of Hematology},
year = {2026},
volume = {101},
number = {12},
pages = {3074--3076},
doi = {10.1002/ajh.70509}
}
EUVIMED